Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following receptors is coupled to a heterotrimeric G protein?

GABA-B receptor. **Explanation:** The core concept tested here is the classification of receptors into **Ionotropic** (ligand-gated ion channels) and **Metabotropic** (G-protein coupled receptors or GPCRs). **Why GABA-B is correct:** The **GABA-B receptor** is a metabotropic receptor coupled to a **heterotrimeric G-protein** (specifically $G_i/G_o$). Activation of GABA-B leads to the inhibition of adenylyl cyclase, opening of potassium ($K^+$) channels (causing hyperpolarization), and closing of calcium ($Ca^{2+}$) channels. This mediates slow, prolonged inhibitory postsynaptic potentials. **Why the other options are incorrect:** * **Glycine receptor (Option A):** This is an **ionotropic** receptor. It is a pentameric chloride ($Cl^-$) channel that mediates fast inhibition in the spinal cord and brainstem. * **Nicotinic ACh receptor (Option C):** The Nm receptor at the neuromuscular junction is a classic **ionotropic** receptor. It is a ligand-gated cation channel ($Na^+/K^+$) that mediates rapid skeletal muscle contraction. * **5-HT3 receptor (Option D):** This is the **only ionotropic serotonin receptor**. All other serotonin receptors (5-HT1, 2, 4–7) are GPCRs. 5-HT3 is a non-selective cation channel involved in the emetic reflex. **High-Yield Clinical Pearls for NEET-PG:** * **GABA-A vs. GABA-B:** Remember "A" for **A**qua/Ion (Ionotropic - $Cl^-$ channel) and "B" for **B**oth/GPCR (Metabotropic). * **Baclofen** is a specific GABA-B agonist used clinically as a centrally acting muscle relaxant for spasticity. * **Fast vs. Slow:** Ionotropic receptors (A, C, D) act in milliseconds, while GPCRs (B) take seconds to minutes. * **Common Ionotropic Receptors (Mnemonic: "GANG"):** **G**ABA-A, **A**MPA/NMDA/Kainate, **N**icotinic, **G**lycine, and 5-HT3.

Q: Which of the following antimicrobial agents does not require dose reduction in patients with renal failure?

Rifampicin. **Explanation:** The primary factor determining whether a drug requires dose adjustment in renal failure is its **route of elimination**. Drugs primarily excreted by the kidneys require dose reduction to prevent toxicity, whereas drugs metabolized by the liver or excreted via bile do not. **1. Why Rifampicin is correct:** Rifampicin is a highly lipid-soluble drug that undergoes extensive **hepatic metabolism** (deacetylation) and is primarily excreted through the **bile and feces**. Since its clearance is independent of renal function, it is safe to use in standard doses in patients with renal impairment. **2. Why the other options are incorrect:** * **Fluconazole:** Unlike other azoles (like Itraconazole), Fluconazole is primarily excreted unchanged in the urine (>80%). It requires significant dose reduction in renal failure. * **Vancomycin:** This glycopeptide is almost exclusively excreted by glomerular filtration. It is highly nephrotoxic; doses must be adjusted based on creatinine clearance or trough levels. * **Imipenem:** This carbapenem is eliminated renally. Furthermore, it is co-administered with Cilastatin to prevent its breakdown by renal dehydropeptidase-I. Accumulation in renal failure increases the risk of seizures. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Antimicrobials safe in Renal Failure:** "**D**on't **C**hange **M**edicine **L**evels" — **D**oxycycline, **C**eftriaxone/Cefoperazone, **M**acrolides (Erythromycin/Azithromycin), **L**inezolid/Lincosamides (Clindamycin). * **Rifampicin** is a potent **Inducer** of Cytochrome P450 enzymes, leading to numerous drug interactions (e.g., reducing the efficacy of OCPs and Warfarin). * **Doxycycline** is the tetracycline of choice in renal failure because it is excreted via the gut.

Q: Which of the following drugs is deposited in the muscles?

Digoxin. **Explanation:** The correct answer is **Digoxin**. This question tests the concept of **Volume of Distribution ($V_d$)** and tissue-specific binding [1]. **1. Why Digoxin is Correct:** Digoxin has an exceptionally large volume of distribution (~5–7 L/kg) because it is extensively sequestered in peripheral tissues, specifically **skeletal muscle** and the heart [1]. It binds to the Na+/K+-ATPase pump in these tissues [1],[3]. Because skeletal muscle represents a large percentage of total body mass, it serves as the primary reservoir for Digoxin [1]. * **Clinical Correlation:** In obese patients, Digoxin dosage should be calculated based on **Lean Body Weight (LBW)** rather than total body weight, as Digoxin does not distribute into adipose tissue. **2. Why the Other Options are Incorrect:** * **Verapamil:** While it has a large $V_d$, it does not show the characteristic high-affinity sequestration in skeletal muscle that Digoxin does. It is primarily metabolized by the liver. * **Adenosine:** It has an extremely short half-life (<10 seconds) because it is rapidly taken up by erythrocytes and endothelial cells and metabolized. It does not have time to deposit in muscles. * **Phenytoin:** It is highly protein-bound (mainly to albumin) and follows zero-order kinetics at high therapeutic concentrations [2]. It does not sequester in skeletal muscle. **High-Yield NEET-PG Pearls:** * **Tissue Reservoirs:** * **Muscle:** Digoxin [1] * **Adipose Tissue:** Thiopental, Amiodarone * **Bone/Teeth:** Tetracyclines, Fluoride * **Retina:** Chloroquine (binds to melanin) * **Liver:** Chloroquine, Emetine * **Digoxin Monitoring:** Since Digoxin is sequestered in muscles, plasma levels do not reflect tissue levels immediately after administration. Blood for Therapeutic Drug Monitoring (TDM) should be drawn at least **6–8 hours** after the last dose to allow for distribution [4].

Q: Lorazepam can be safely used as a preanesthetic medication in a patient undergoing liver transplantation without fear of excessive CNS depression because the drug is:

conjugated extrahepatically. **Explanation:** The correct answer is **C. conjugated extrahepatically.** **Concept:** Benzodiazepines (BZDs) are primarily metabolized in the liver via two pathways: 1. **Phase I (Oxidation):** Carried out by Cytochrome P450 enzymes. This process is significantly impaired in liver disease and often produces active metabolites with long half-lives (e.g., Diazepam). 2. **Phase II (Conjugation):** Glucuronidation converts the drug into inactive, water-soluble metabolites. Crucially, glucuronidation is relatively preserved in hepatic failure and can also occur **extrahepatically** (e.g., in the kidneys). Lorazepam, along with Oxazepam and Temazepam (remembered by the mnemonic **LOT**), undergoes direct Phase II conjugation without requiring Phase I oxidation. Therefore, even in a patient undergoing liver transplantation (severe hepatic impairment), Lorazepam does not accumulate to toxic levels, making it safer than other BZDs. **Analysis of Incorrect Options:** * **Option A:** Most BZDs are highly lipid-soluble and must be metabolized to water-soluble forms before excretion; they are not excreted unchanged. * **Option B:** BZDs are primarily excreted via the renal route after conjugation, not through active GI secretion. * **Option C:** Lorazepam is a potent CNS depressant. While it is used as an anxiolytic, it can cause significant sedation and respiratory depression at higher doses. **NEET-PG High-Yield Pearls:** * **LOT Drugs:** **L**orazepam, **O**xazepam, and **T**emazepam are the BZDs of choice in elderly patients and those with liver cirrhosis/failure. * **Midazolam:** Commonly used as a preanesthetic due to its short half-life and prominent **anterograde amnesia**, but it requires Phase I oxidation and is less safe in liver failure than Lorazepam. * **Flumazenil:** The specific antidote for BZD overdose (competitive antagonist at the GABA-A receptor).

Q: Urinary alkalinizing agents are administered in case of poisoning due to which type of drugs?

Weak acids. **Explanation:** The principle behind urinary alkalinization is the **Ion Trapping Phenomenon**, which is governed by the Henderson-Hasselbalch equation. **1. Why Weak Acids are the Correct Answer:** Weakly acidic drugs (e.g., Salicylates, Phenobarbitone) exist in an equilibrium between ionized (charged) and unionized (uncharged) forms. In an alkaline medium (high pH), weak acids become **ionized**. Since ionized molecules are lipid-insoluble, they cannot diffuse back across the renal tubular epithelium into the bloodstream. This "traps" the drug in the tubular lumen, significantly increasing its renal clearance and excretion. **2. Why the Other Options are Incorrect:** * **Weak Bases:** In an alkaline urine, weak bases remain unionized (lipid-soluble), allowing them to be easily reabsorbed into the systemic circulation. To enhance the excretion of weak bases (e.g., Amphetamines), **urinary acidification** (using Ammonium Chloride) is required. * **Strong Acids/Bases:** These are already highly ionized at physiological pH levels. Their excretion is generally not significantly altered by minor shifts in urinary pH achieved through clinical alkalinization. **Clinical Pearls for NEET-PG:** * **Agent of Choice:** **Sodium Bicarbonate ($NaHCO_3$)** is the standard agent used to alkalinize urine (Target pH: 7.5–8.5). * **Classic Examples:** Forced alkaline diuresis is most commonly tested for **Salicylate (Aspirin)** and **Barbiturate** poisoning. * **Contraindication:** Do not alkalinize urine in patients with renal failure or congestive heart failure due to the risk of fluid and sodium overload. * **Mnemonic:** **"Like dissolves in Like"** (Unionized/Absorbed); **"Opposites Ionize"** (Ionized/Excreted). Acidic drug + Basic urine = Excretion.

Q: Detoxification of drugs is primarily controlled by which enzyme system?

Cytochrome P450. **Explanation:** The detoxification of drugs (biotransformation) is primarily mediated by the **Cytochrome P450 (CYP450)** enzyme system. These are a superfamily of heme-containing enzymes located mainly in the smooth endoplasmic reticulum of hepatocytes. They catalyze **Phase I reactions**, primarily oxidation, which increase the polarity of lipophilic drugs to facilitate their excretion from the body. **Why the other options are incorrect:** * **Cytochrome:** This is a general term for a broad class of hemeproteins involved in electron transport. It is too non-specific to describe drug metabolism. * **Cytochrome C:** This is a specific component of the mitochondrial electron transport chain (ETC) essential for ATP production and apoptosis; it does not play a role in xenobiotic metabolism. * **Cytochrome A:** This is a component of Cytochrome c oxidase (Complex IV) in the mitochondrial respiratory chain, involved in the final step of electron transfer to oxygen. **High-Yield NEET-PG Pearls:** * **CYP3A4:** The most abundant isoform in the liver and responsible for metabolizing approximately 50% of all clinical drugs. * **CYP2D6:** Shows significant **genetic polymorphism**, affecting the metabolism of drugs like codeine (pro-drug activation) and metoprolol. * **Inducers vs. Inhibitors:** Knowledge of CYP inducers (e.g., Rifampicin, Phenytoin, Carbamazepine) and inhibitors (e.g., Ketoconazole, Erythromycin, Grapefruit juice) is crucial for identifying potential drug-drug interactions. * **Microsomal Enzymes:** CYP450 enzymes are "microsomal," meaning they are found in the microsomal fraction of liver homogenates (derived from the ER).

Q: Which of the following drugs affect CYP 3A4 enzymes?

Phenytoin. **Explanation:** The Cytochrome P450 (CYP) enzyme system is the primary pathway for drug metabolism in the liver. **Phenytoin** is a potent **inducer** of the CYP 3A4 isoenzyme. By inducing these enzymes, phenytoin increases the metabolic rate of co-administered drugs (e.g., oral contraceptives, warfarin), leading to decreased therapeutic efficacy. **Analysis of Options:** * **Phenytoin (Correct):** A classic microsomal enzyme inducer. It increases the synthesis of CYP enzymes, specifically 3A4 and 2C9/2C19. * **Carbamazepine:** While Carbamazepine is also a potent CYP 3A4 inducer, in the context of standard NEET-PG questions where a single best answer is required and Phenytoin is listed, Phenytoin is often the prototypical example used. *Note: In many clinical scenarios, both B and C would be technically correct as they are both "Big Inducers."* * **Fexofenadine:** This is a second-generation antihistamine known for being a "non-sedating" metabolite of terfenadine. It does not significantly induce or inhibit CYP enzymes, making it safer regarding drug-drug interactions. * **Azithromycin:** Unlike other macrolides (Erythromycin, Clarithromycin), Azithromycin does **not** significantly inhibit CYP 3A4. This is a high-yield distinction often tested to differentiate it from its class members. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Mnemonic for Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**erfenadine, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**itrofurantoin, **K**etoconazole. * **Grapefruit juice** is a specific and potent inhibitor of intestinal CYP 3A4.

Question 1

Which of the following receptors is coupled to a heterotrimeric G protein?

Accepted Answer

GABA-B receptor

Answer

Glycine receptor

Answer

Nicotinic acetylcholine receptor at myoneural junction

Answer

5-HT3 receptor

Question 2

Which of the following antimicrobial agents does not require dose reduction in patients with renal failure?

Accepted Answer

Rifampicin

Answer

Fluconazole

Answer

Vancomycin

Answer

Imipenem

Question 3

Which of the following drugs is deposited in the muscles?

Accepted Answer

Digoxin

Answer

Verapamil

Answer

Adenosine

Answer

Phenytoin

Question 4

Lorazepam can be safely used as a preanesthetic medication in a patient undergoing liver transplantation without fear of excessive CNS depression because the drug is:

Accepted Answer

conjugated extrahepatically

Answer

excreted in unchanged form

Answer

actively secreted into the GI tract

Answer

a selective anxiolytic devoid of CNS depressant actions

Question 5

Urinary alkalinizing agents are administered in case of poisoning due to which type of drugs?

Accepted Answer

Weak acids

Answer

Weak bases

Answer

Strong bases

Answer

Strong acids

Question 6

Detoxification of drugs is primarily controlled by which enzyme system?

Accepted Answer

Cytochrome P450

Answer

Cytochrome

Answer

Cytochrome C

Answer

Cytochrome A

Question 7

The volume of plasma from which a substance is completely removed by filtration and secretion in the kidney is equal to which of the following?

Accepted Answer

Clearance

Answer

Rate of elimination

Answer

Volume of distribution

Answer

Bioavailability

Question 8

Which of the following drugs affect CYP 3A4 enzymes?

Accepted Answer

Phenytoin

Answer

Fexofenadine

Answer

Carbamazepine

Answer

Azithromycin

Question 9

Volume of distribution is NOT affected by all EXCEPT?

Accepted Answer

Binding to plasma protein

Answer

Drug clearance

Answer

Lipid insolubility

Answer

Absence of blood brain barrier

Question 10

An elderly patient presents with myocardial infarction and a severe ventricular arrhythmia. The chosen antiarrhythmic drug has a narrow therapeutic window, with a minimum toxic plasma concentration 1.5 times the minimum therapeutic plasma concentration. The drug's half-life is 6 hours. It is crucial to maintain the plasma concentration above the minimum therapeutic level to prevent lethal arrhythmia. Which of the following dosing regimens is most appropriate?

Accepted Answer

Constant intravenous infusion

Answer

Once daily

Answer

Twice daily

Answer

Four times daily

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?